MHC class II-deficient mice allow functional human CD4⁺ T-cell development.

Area of Science:

• Immunology
• Infectious Diseases
• Transplantation

Background:

• Humanized mouse models are crucial for studying human immune responses to pathogens.
• The selection of human T cells within the murine thymus of these models is not well understood.
• Investigating T cell differentiation in immunocompromised mice offers insights into immune cell development.

Purpose of the Study:

• To explore the differentiation of human immune cells in mouse MHC class II-deficient mice (humanized Ab0 mice).
• To understand the impact of reduced CD4+ T cell development on immune responses to Epstein-Barr virus (EBV).
• To investigate the selection and function of human T cells in a humanized mouse model.

Main Methods:

• Developed humanized Ab0 mice with MHC class II deficiency.
• Compared EBV infection control and viral loads in humanized Ab0 and NSG mice.
• Assessed T cell recognition and cytotoxicity against EBV-transformed B cells.
• Conducted MHC class II blocking experiments with CD4+ T cells.

Main Results:

• Human CD4+ T-cell development was significantly reduced in humanized Ab0 mice.
• Despite reduced T cells, Ab0 mice controlled EBV infection as effectively as NSG mice.
• Enhanced T-cell recognition and cytotoxicity against EBV-transformed B cells were observed.
• MHC class II restriction of T-cell recognition was confirmed.

Conclusions:

• A limited number of human CD4+ T cells can be selected by human MHC class II molecules in reconstituted human immune cells.
• These selected T cells exhibit improved effector functions, including cytotoxicity.
• This suggests a potential for effective cell-mediated immunity even with reduced T cell populations in humanized models.